Assignee
VIVET THERAPEUTICS
FR·1 granted patent·3 pending applications·0 citations·filing 2019–2021
Top patents by PatentIndex Score
4 records- 0145US12385063B2Codon-optimized ABCB11 transgene for the treatment of progressive familial intrahepatic cholestasis type 2 (PFIC2)VIVET THERAPEUTICS·Filed 2019·Granted Aug 12, 2025·0 cites·19 claims
- 0240US2024091382A1Minimal bile acid inducible promoters for gene therapyVIVET THERAPEUTICS·Filed 2021·Application pending·0 cites
- 0336US2021180084A1Gene therapy vectors comprising s/mar sequencesVIVET THERAPEUTICS·Filed 2019·Application pending·0 cites
- 0430US2021292791A1Codon-optimized transgene for the treatment of progressive familiar intrahepatic cholestasis type 3 (pfic3)VIVET THERAPEUTICS·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VIVET THERAPEUTICS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →